These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1595 related items for PubMed ID: 26208996

  • 1. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL, Theron G, Khalfey H, Peter J, Meldau R, Matinyenya B, Davids M, Smith L, Pooran A, Lesosky M, Esmail A, Miller MG, Piercy J, Michell L, Dawson R, Raine RI, Joubert I, Dheda K.
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [Abstract] [Full Text] [Related]

  • 2. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K, TB-NEAT team.
    Lancet; 2014 Feb 01; 383(9915):424-35. PubMed ID: 24176144
    [Abstract] [Full Text] [Related]

  • 3. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ, Workman L, Isaacs W, Dheda K, Zemanay W, Nicol MP.
    Lancet Glob Health; 2013 Aug 01; 1(2):e97-e104. PubMed ID: 25104164
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, Phillips PP, Venter A, Bateson A, Boehme CC, Heinrich N, Hunt RD, Boeree MJ, Zumla A, McHugh TD, Gillespie SH, Diacon AH, Hoelscher M, Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA).
    Lancet Respir Med; 2013 Aug 01; 1(6):462-70. PubMed ID: 24429244
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M, O'Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A.
    Lancet Infect Dis; 2013 Jan 01; 13(1):36-42. PubMed ID: 23134697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
    Di Tanna GL, Khaki AR, Theron G, McCarthy K, Cox H, Mupfumi L, Trajman A, Zijenah LS, Mason P, Bandason T, Durovni B, Bara W, Hoelscher M, Clowes P, Mangu C, Chanda D, Pym A, Mwaba P, Cobelens F, Nicol MP, Dheda K, Churchyard G, Fielding K, Metcalfe JZ.
    Lancet Glob Health; 2019 Feb 01; 7(2):e191-e199. PubMed ID: 30683238
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.
    Cochrane Database Syst Rev; 2014 Jan 21; 2014(1):CD009593. PubMed ID: 24448973
    [Abstract] [Full Text] [Related]

  • 10. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW, González Fernández L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM.
    Cochrane Database Syst Rev; 2020 Aug 27; 8(8):CD013359. PubMed ID: 32853411
    [Abstract] [Full Text] [Related]

  • 11. Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial.
    Calligaro GL, Zijenah LS, Peter JG, Theron G, Buser V, McNerney R, Bara W, Bandason T, Govender U, Tomasicchio M, Smith L, Mayosi BM, Dheda K.
    Lancet Infect Dis; 2017 Apr 27; 17(4):441-450. PubMed ID: 28063795
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW, Tameris M, Geldenhuys H, Schmidt BM, Luabeya AK, Mulenga H, Scriba TJ, Hanekom WA, Mahomed H, McShane H, Hatherill M.
    PLoS One; 2015 Apr 27; 10(11):e0141623. PubMed ID: 26554383
    [Abstract] [Full Text] [Related]

  • 13. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J, Nguyen PTB, Nguyen TA, Tran KH, Van Nguyen S, Nguyen NV, Nguyen HB, Luu KB, Fox GJ, Marks GB.
    Lancet Infect Dis; 2016 Sep 27; 16(9):1045-1051. PubMed ID: 27289387
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.
    Am J Respir Crit Care Med; 2011 Jul 01; 184(1):132-40. PubMed ID: 21493734
    [Abstract] [Full Text] [Related]

  • 15. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
    Singh S, Singh A, Prajapati S, Kabra SK, Lodha R, Mukherjee A, Singh V, Hesseling AC, Grewal HM, Delhi Pediatric TB study group.
    BMC Microbiol; 2015 Sep 29; 15():191. PubMed ID: 26420261
    [Abstract] [Full Text] [Related]

  • 16. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, Mehta N, Calligaro G, Lombard CJ, Kadzirange G, Bandason T, Chansa A, Liusha N, Mangu C, Mtafya B, Msila H, Rachow A, Hoelscher M, Mwaba P, Theron G, Dheda K.
    Lancet; 2016 Mar 19; 387(10024):1187-97. PubMed ID: 26970721
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A.
    Clin Infect Dis; 2012 Nov 19; 55(9):1171-8. PubMed ID: 22806590
    [Abstract] [Full Text] [Related]

  • 18. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.
    Lancet; 2011 Apr 30; 377(9776):1495-505. PubMed ID: 21507477
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.
    PLoS Med; 2011 Jul 30; 8(7):e1001061. PubMed ID: 21814495
    [Abstract] [Full Text] [Related]

  • 20. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O, Senn L, Prod'hom G, Mazza-Stalder J, Tissot F, Greub G, Jaton K.
    Clin Microbiol Infect; 2016 Jul 30; 22(7):613-9. PubMed ID: 27139592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.